Interview with Vanrx CEO Featured in BioProcess International Special Report

admin | Thursday, February 25th, 2010 | No Comments »

Christopher Procyshyn, CEO of Vanrx PharmaSystems, discusses the current state of automation in the bioprocess industry and provides insight on its continued development.

… Procyshyn pointed out that the pick-and-placement and visual analysis functions in fill and finish are ideal for automation. “One thing we’re focusing on is developing tools and techniques for use in areas where isolator technology and peroxide sterilization is possible.” …

 

Link to full article…

Comments are closed.